Related references
Note: Only part of the references are listed.Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse
Randi-Michelle Cowin et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Huntingtin Aggregation Kinetics and Their Pathological Role in a Drosophila Huntington's Disease Model
Kurt R. Weiss et al.
GENETICS (2012)
Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins
David C. Butler et al.
PROGRESS IN NEUROBIOLOGY (2012)
Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila
Yasmina Talmat-Amar et al.
HUMAN MOLECULAR GENETICS (2011)
Secondary Structures of Native and Pathogenic Huntingtin N-Terminal Fragments
Maciej Dlugosz et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Small Changes, Big Impact: Posttranslational Modifications and Function of Huntingtin in Huntington Disease
Dagmar E. Ehrnhoefer et al.
NEUROSCIENTIST (2011)
Perturbation with Intrabodies Reveals That Calpain Cleavage Is Required for Degradation of Huntingtin Exon 1
Amber L. Southwell et al.
PLOS ONE (2011)
Early or Late-Stage Anti-N-Terminal Huntingtin Intrabody Gene Therapy Reduces Pathological Features in B6.HDR6/1 Mice
Abigail Snyder-Keller et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein
Peter O. Bauer et al.
NATURE BIOTECHNOLOGY (2010)
Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
John P. Miller et al.
NEURON (2010)
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Chiara Zuccato et al.
PHYSIOLOGICAL REVIEWS (2010)
Small molecule drug discovery for Huntington's Disease
Wolfgang Fecke et al.
DRUG DISCOVERY TODAY (2009)
Genomic mapping and expression patterns of C380, OK6 and D42 enhancer trap lines in the larval nervous system of Drosophila
Subhabrata Sanyal
GENE EXPRESSION PATTERNS (2009)
Intrabody Gene Therapy Ameliorates Motor, Cognitive, and Neuropathological Symptoms in Multiple Mouse Models of Huntington's Disease
Amber L. Southwell et al.
JOURNAL OF NEUROSCIENCE (2009)
Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments
Simon C. Warby et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin
Gerardo A. Morfini et al.
NATURE NEUROSCIENCE (2009)
The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation
Stephen Tam et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism
Ashwani K. Thakur et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons
C. Sinadinos et al.
NEUROBIOLOGY OF DISEASE (2009)
Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease
J. A. McLear et al.
FASEB JOURNAL (2008)
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
Diana Zala et al.
HUMAN MOLECULAR GENETICS (2008)
Protective role of Engrailed in a Drosophila model of Huntington's disease
Bruno Mugat et al.
HUMAN MOLECULAR GENETICS (2008)
Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity
Amber L. Southwell et al.
JOURNAL OF NEUROSCIENCE (2008)
Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm
Eliana Romero et al.
NEURON (2008)
Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo
H. Akiko Popiel et al.
MOLECULAR THERAPY (2007)
Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease
Jeremy M. Van Raamsdonk et al.
BMC NEUROSCIENCE (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
Flanking sequences profoundly alter polyglutamine toxicity in yeast
Martin L. Duennwald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin
Y Tanaka et al.
NEUROBIOLOGY OF DISEASE (2006)
Normal huntingtin function: An alternative approach to Huntington's disease
E Cattaneo et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions
EJ Slow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
WJ Wolfgang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease
JM Van Raamsdonk et al.
HUMAN MOLECULAR GENETICS (2005)
Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease
WCM Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Shaggy, the homolog of glycogen synthase kinase 3, controls neuromuscular junction growth in Drosophila
B Franco et al.
JOURNAL OF NEUROSCIENCE (2004)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
The Drosophila metabotropic glutamate receptor DmGluRA regulates activity-dependent synaptic facilitation and fine synaptic morphology
L Bogdanik et al.
JOURNAL OF NEUROSCIENCE (2004)
Inhibition of calpain cleavage of huntingtin reduces toxicity - Accumulation of calpain/caspase fragments in the nucleus
J Gafni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Disruption of axonal transport by loss of huntingtin or expression of pathogenic PolyQ proteins in Drosophila
S Gunawardena et al.
NEURON (2003)
The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor
Hiroki Takano et al.
BMC NEUROSCIENCE (2002)
Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity
A Khoshnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Identification of genes that modify ataxin-1-induced neurodegeneration
P Fernandez-Funez et al.
NATURE (2000)
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
I Dragatsis et al.
NATURE GENETICS (2000)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
Share Paper
